Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5,2,0]non-1(7)-en2-yl]ethylphosphonic Acid) and EAB-318 (R-α-amino-5-chloro-1-(phosphonomethyl)-1h-benzimidazole-2- propanoic acid hydrochloride)

Medicine & Life Sciences

• R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride 100%
• EAA-090 90%
• benzimidazole 57%
• propionic acid 53%
• N-Methylaspartate 43%
• selfotel 35%
• Acids 30%
• N-Methyl-D-Aspartate Receptors 25%
• Neurons 9%
• Inhibitory Concentration 50 9%
• 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid 8%
• Kainic Acid Receptors 6%
• alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid 6%
• AMPA Receptors 5%
• Chick Embryo 5%
• Kainic Acid 5%
• Electrophysiology 5%
• Xenopus 5%
• Neuroprotection 5%
• Oocytes 4%
• Glutamic Acid 4%
• Retina 4%
• Cell Death 3%
• Ischemia 3%
• Ligands 3%